Insulinepen vial 3mlAlso known as: 3 ml insulin pen vial, insulin pen cartridge vial

Mechanism of Action

Not applicable. This product is a 3 ml vial designed for use with insulin pens to allow accurate and sterile delivery of peptides such as BPC-157 in laboratory settings. It does not have a pharmacological mechanism itself but serves as a delivery tool ensuring precise dosing and peptide stability during experimental administration.

Reported Research Benefits

Used for precise, sterile dosing of peptide research compounds via insulin pens in laboratory and research environments. Commonly used with peptides like BPC-157 for preclinical research studies requiring controlled dosing.

Dosing Protocol & Reconstitution

This vial is designed for single use; dosing depends on the peptide administered using the insulin pen. Common laboratory dosing protocols for peptides (e.g., BPC-157) via insulin pen administration are followed, typically in microliter volumes adjusted per experiment.

Research Notes

Ensures sterile, single-use containment of peptides for research to maintain integrity and prevent cross-contamination. Ideal for peptides sensitive to degradation by preventing repeated vial access.

Research Summary

The Insulinepen vial 3ml is primarily a medical delivery device designed to store and administer insulin and other peptides, such as BPC-157, through insulin pens. While there are extensive clinical and preclinical studies regarding insulin and peptides like BPC-157, the vial itself is not an active pharmacological agent. Its role in research and clinical practice is to facilitate accurate dosing and maintain sterility during administration. Research on the vial focuses on its usage efficiency and reliability as a container rather than therapeutic effects. Consequently, evidence is based on product validation and usability rather than clinical trials of a pharmacological nature.

Side Effects & Safety

As a delivery device, the Insulinepen vial 3ml does not have inherent pharmacological side effects. However, safety considerations mainly relate to maintaining sterility to prevent infections or contamination when handling peptides or insulin. Incorrect handling or breakage may lead to dosing errors or compromised peptide stability. There are no known direct drug interactions or systemic effects caused by the vial itself. Since it is a medical container, World Anti-Doping Agency (WADA) regulations are not applicable to the vial, though peptides administered using it may be subject to anti-doping rules. Proper storage and usage following standard medical guidelines are essential to ensure safety.

Stability & Storage

Refer to research notes

Molecular Data

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=insulinepen+vial+3ml